Arimidex Description: Arimidex (anastrozole) is an anti-estrogenic drug developed for the treatment of advanced breast cancer in women. Specifically, this agent is the first in a newer class of third-generation selective oral aromatase inhibitors.646
Aromasin Description: Aromasin (exemestane) is a steroidal suicide aromatase inhibitor. It is very similar in structure and action to formestane, although it is significantly more potent in comparison. As a class of drugs, aromatase
Clomid Description: Clomid (clomiphene citrate) is an anti-estrogenic drug that is prescribed to women to treat anovulatory infertility, or an inability to ovulate. In clinical medicine it is specifically referred to as a nonsteroidal ovulatory
Formestane Description: Formestane is classified as a selective irreversible steroidal aromatase inhibitor. This agent is structurally a derivative of androstenedione, differing from this well known prohormone only by the addition of a 4-hydroxyl group.
Letrozole Description: Letrozole is a non-steroidal selective third generation aromatase inhibitor. The structure and activity of this compound are very similar to that of Arimidex (anastrozole), and it is prescribed for similar medical purposes.
Nolvadex Description: Nolvadex (tamoxifen citrate) is a non-steroidal anti-estrogenic drug, used widely in clinical medicine. It is specifically a Selective Estrogen-Receptor Modulator (SERM) of the triphenylethylene family, and possesses both estrogen agonist and antagonist
Raloxifene HCL Description: Raloxifene hydrochloride is a second-generation Selective Estrogen Receptor Modulator (SERM) of the benzothiophene family. This drug is similar in effect to tamoxifen, exhibiting estrogen receptor antagonist (blocking) properties in some tissues